Regeneron Pharmaceuticals Files 8-K on Financials
Ticker: REGN · Form: 8-K · Filed: 2026-04-08T07:05:58-04:00
Sentiment: neutral
Topics: financial-results, 8-k
Related Tickers: REGN
TL;DR
REGN filed an 8-K on 4/8/26 with financial updates.
AI Summary
Regeneron Pharmaceuticals, Inc. filed an 8-K on April 8, 2026, reporting results of operations and financial condition. The filing includes various XBRL documents detailing financial information for the period ending April 8, 2026. The company's mailing and business address is 777 Old Saw Mill River Road, Tarrytown, NY 10591.
Why It Matters
This 8-K filing provides investors with crucial updates on Regeneron's financial performance and operational status as of April 8, 2026.
Risk Assessment
Risk Level: low — This filing is a routine 8-K reporting financial results and does not indicate any unusual or significant risks.
Key Players & Entities
- REGENERON PHARMACEUTICALS, INC. (company) — Filer
- 0000872589 (company) — CIK
- 2026-04-08 (date) — Filing Date and Period of Report
- 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 (location) — Mailing and Business Address
FAQ
What type of report is this 8-K filing?
This is a Current Report on Form 8-K, filed by Regeneron Pharmaceuticals, Inc.
When was this 8-K filing accepted by the SEC?
The filing was accepted on April 8, 2026, at 07:05:58.
What is the CIK number for Regeneron Pharmaceuticals, Inc.?
The CIK number for Regeneron Pharmaceuticals, Inc. is 0000872589.
What is the business address of Regeneron Pharmaceuticals, Inc.?
The business address is 777 Old Saw Mill River Road, Tarrytown, NY 10591.
What specific item is reported in this 8-K filing?
This 8-K filing reports on Item 2.02: Results of Operations and Financial Condition.
From the Filing
EDGAR Filing Documents for 0001104659-26-040661 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 8-K - Current report: SEC Accession No. 0001104659-26-040661 Filing Date 2026-04-08 Accepted 2026-04-08 07:05:58 Documents 11 Period of Report 2026-04-08 Items Item 2.02: Results of Operations and Financial Condition Interactive Data Document Format Files Seq Description Document Type Size 1 FORM 8-K tm2611354d1_8k.htm iXBRL 8-K 28690 Complete submission text file 0001104659-26-040661.txt 193470 Data Files Seq Description Document Type Size 2 XBRL TAXONOMY EXTENSION SCHEMA regn-20260408.xsd EX-101.SCH 3017 3 XBRL TAXONOMY EXTENSION LABEL LINKBASE regn-20260408_lab.xml EX-101.LAB 34239 4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE regn-20260408_pre.xml EX-101.PRE 22360 14 EXTRACTED XBRL INSTANCE DOCUMENT tm2611354d1_8k_htm.xml XML 3121 Mailing Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 Business Address 777 OLD SAW MILL RIVER ROAD TARRYTOWN NY 10591 9148477000 REGENERON PHARMACEUTICALS, INC. (Filer) CIK : 0000872589 (see all company filings) EIN. : 133444607 | State of Incorp.: NY | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 000-19034 | Film No.: 26846512 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences)